Maria Herrero-Garcia

5PUBLICATIONS
50CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

|Dec 31, 2025
Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients.

Sara Gutiérrez-Herrero, Lourdes Martín-Martín, María Herrero-García

|May 17, 2024
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients.

Lourdes Martín-Martín, Sara Gutiérrez-Herrero, María Herrero-García

|Apr 12, 2022
The Urinary Level of Injury Biomarkers Is Not Univocally Reflective of the Extent of Toxic Renal Tubular Injury in Rats.

Sandra M Sancho-Martínez, María Herrero, Miguel Fontecha-Barriuso

|May 10, 2019
Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency.

Ignacio García-Tuñón, Verónica Alonso-Pérez, Elena Vuelta

Pageof 1

Frequent Collaborators

3 joint publications

Alberto Orfao

2 joint publications

Fermín Sánchez-Guijo

2 joint publications

Lucía López-Corral

2 joint publications

Lourdes Martín-Martín